Omega Fund Management, LLC
- SEC CIK
- 0001637359
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 26
- +3 vs. Q2 2021
- Portfolio value
- $891.4M
- +$7.78M (+0.9%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NUVBNuvation Bio Inc. | COM CL A | 28,212,376 | $280.4M | 31.5% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 4,896,074 | $145.1M | 16.3% | −112,171−2.2% | Reduced | History |
| KRONKronos Bio, Inc. | COM | 3,818,283 | $80.0M | 9.0% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 1,315,952 | $74.5M | 8.4% | −451,398−25.5% | Reduced | History |
| IMGOImago BioSciences, Inc. | COM | 3,018,737 | $60.5M | 6.8% | +3,018,737 | New | History |
| GOSSGossamer Bio, Inc. | COM | 3,320,608 | $41.7M | 4.7% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 2,249,123 | $28.4M | 3.2% | 00.0% | Unchanged | History |
| IVVDInvivyd, Inc. | COM | 632,855 | $26.7M | 3.0% | +632,855 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 2,029,580 | $21.7M | 2.4% | +744,680+58.0% | Added | History |
| SANASana Biotechnology, Inc. | COM | 843,750 | $19.0M | 2.1% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 1,788,160 | $15.8M | 1.8% | 00.0% | Unchanged | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 623,836 | $14.9M | 1.7% | 00.0% | Unchanged | History |
| SPRBSpruce Biosciences, Inc. | COM | 2,161,022 | $13.0M | 1.5% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 2,606,809 | $12.7M | 1.4% | +6,399+0.2% | Added | History |
| ICVXIcosavax, Inc. | COM | 426,395 | $12.6M | 1.4% | +426,395 | New | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 2,512,705 | $11.2M | 1.3% | +237,874+10.5% | Added | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 164,577 | $5.77M | 0.6% | −582,291−78.0% | Reduced | History |
| CMPICheckmate Pharmaceuticals, Inc. | COM | 1,335,050 | $5.30M | 0.6% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 501,000 | $4.88M | 0.5% | 00.0% | Unchanged | – |
| CDTXCidara Therapeutics, Inc. | COM | 2,005,249 | $4.49M | 0.5% | 00.0% | Unchanged | History |
| OBSVObsEva SA | COM | 999,364 | $3.11M | 0.3% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 328,196 | $2.63M | 0.3% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 275,513 | $2.05M | 0.2% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 51,535 | $1.91M | 0.2% | 00.0% | Unchanged | History |
| TRVITrevi Therapeutics, Inc. | COM | 1,263,408 | $1.77M | 0.2% | 00.0% | Unchanged | History |
| KYNBKyntra Bio, Inc. | COM | 130,646 | $1.15M | 0.1% | 00.0% | Unchanged | History |